These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38349420)

  • 1. Factors associated with the development of exudation in treatment-naive eyes with nonexudative macular neovascularization.
    Cho HJ; Kim M; Kim J; Yoon I; Park S; Kim CG
    Graefes Arch Clin Exp Ophthalmol; 2024 Jul; 262(7):2073-2082. PubMed ID: 38349420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-Year Risk of Exudation in Eyes with Nonexudative Age-Related Macular Degeneration and Subclinical Neovascularization Detected with Swept Source Optical Coherence Tomography Angiography.
    Yang J; Zhang Q; Motulsky EH; Thulliez M; Shi Y; Lyu C; de Sisternes L; Durbin MK; Feuer W; Wang RK; Gregori G; Rosenfeld PJ
    Am J Ophthalmol; 2019 Dec; 208():1-11. PubMed ID: 31229464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonexudative Macular Neovascularization - A Systematic Review of Prevalence, Natural History, and Recent Insights from OCT Angiography.
    Laiginhas R; Yang J; Rosenfeld PJ; Falcão M
    Ophthalmol Retina; 2020 Jul; 4(7):651-661. PubMed ID: 32335033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity.
    Wang Y; Sun J; Wu J; Jia H; Feng J; Chen J; Yan Q; Huang P; Wang F; Bo Q; Sun X
    Eye (Lond); 2023 Jul; 37(10):2048-2054. PubMed ID: 36434285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic Predictors and Temporal Characteristics of Conversion from Nonexudative to Exudative Age-Related Macular Degeneration in the Fellow Eye.
    Teo KYC; Yanagi Y; Wong TY; Charkaravarty U; Gemmy Cheung CM
    Ophthalmol Retina; 2021 Feb; 5(2):126-140. PubMed ID: 32679204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY PARAMETER VARIATIONS AFTER TREATMENT OF MACULAR NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Arrigo A; Aragona E; Bordato A; Amato A; Borghesan F; Bandello F; Parodi MB
    Retina; 2021 Jul; 41(7):1463-1469. PubMed ID: 33315820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Nonexudative Choroidal Neovascularization and Progression to Exudative Choroidal Neovascularization Using OCT Angiography.
    Bailey ST; Thaware O; Wang J; Hagag AM; Zhang X; Flaxel CJ; Lauer AK; Hwang TS; Lin P; Huang D; Jia Y
    Ophthalmol Retina; 2019 Aug; 3(8):629-636. PubMed ID: 31068262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonexudative Macular Neovascularization Supporting Outer Retina in Age-Related Macular Degeneration: A Clinicopathologic Correlation.
    Chen L; Messinger JD; Sloan KR; Swain TA; Sugiura Y; Yannuzzi LA; Curcio CA; Freund KB
    Ophthalmology; 2020 Jul; 127(7):931-947. PubMed ID: 32247535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OUTER RETINAL TUBULATION MAY RESULT FROM FIBROSED TYPE 2 NEOVASCULARIZATION: Clinical Observations and Model of Pathogenesis.
    Janse van Rensburg E; Ryu CL; Rampakakis E; Vila N; Chan EW; Chen JC
    Retina; 2021 Sep; 41(9):1930-1939. PubMed ID: 33492078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MORPHOLOGICAL BIOMARKERS PREDICTING EXUDATIVE CONVERSION IN TYPE 1 NONEXUDATIVE MACULAR NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Bae SH; Bae K; Yoon CK; Park UC; Park KH; Lee EK
    Retina; 2024 Jun; 44(6):1006-1014. PubMed ID: 38346091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
    Inan S; Polat O; Karadas M; Inan UU
    Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative Optical Coherence Tomography Detection of New Neovascular Branches and Association With Exudation Recurrence in Neovascular Age-Related Macular Degeneration.
    Arrigo A; Aragona E; Del Fabbro S; Balduzzi E; Parodi MB; Bandello F
    Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):30. PubMed ID: 38899961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural History of Subclinical Neovascularization in Nonexudative Age-Related Macular Degeneration Using Swept-Source OCT Angiography.
    de Oliveira Dias JR; Zhang Q; Garcia JMB; Zheng F; Motulsky EH; Roisman L; Miller A; Chen CL; Kubach S; de Sisternes L; Durbin MK; Feuer W; Wang RK; Gregori G; Rosenfeld PJ
    Ophthalmology; 2018 Feb; 125(2):255-266. PubMed ID: 28964581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Pro Re Nata Regimen with Anti-VEGF on Type 3 Macular Neovascularization: Long-Term Outcomes.
    Toto L; Viggiano P; Quarta A; Grassi M; De Nicola C; Aloia R; D'Aloisio R; Boscia G; Boscia F; Porreca A; Di Nicola M; Savastano MC; Mastropasqua R
    Ophthalmic Res; 2024; 67(1):282-291. PubMed ID: 38621369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUB-RETINAL PIGMENT EPITHELIUM MULTILAMINAR HYPERREFLECTIVITY AT THE ONSET OF TYPE 3 MACULAR NEOVASCULARIZATION.
    Miere A; Sacconi R; Amoroso F; Capuano V; Jung C; Bandello F; Souied EH; Querques G
    Retina; 2021 Jan; 41(1):135-143. PubMed ID: 32282662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: An Optical Coherence Tomographic Angiography Analysis.
    Christenbury JG; Phasukkijwatana N; Gilani F; Freund KB; Sadda S; Sarraf D
    Retina; 2018 Jul; 38(7):1276-1288. PubMed ID: 28723848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of age-related macular degeneration with poor response to three loading doses of anti-vascular endothelial growth factor.
    Sariyeva Ismayilov A; Duru Y; Çağlar T; Erseven C; Ulusoy MO
    Int Ophthalmol; 2024 Jun; 44(1):264. PubMed ID: 38913217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography.
    Maruyama-Inoue M; Sato S; Yamane S; Kadonosono K
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2089-2096. PubMed ID: 30173338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choriocapillaris Flow Deficits and Treatment-Naïve Macular Neovascularization Secondary to Age-Related Macular Degeneration.
    Scharf JM; Corradetti G; Alagorie AR; Grondin C; Hilely A; Wang D; Sadda S; Sarraf D
    Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):11. PubMed ID: 32902576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.